Remove Angioplasty Remove Myocardial Infarction Remove Outcomes
article thumbnail

Impact of Diabetes on Outcomes in Left Main Coronary Revascularization: PCI vs. CABG

Cardiology Update

Left main coronary artery disease (CAD) and diabetes pose significant challenges in cardiovascular care, often leading to adverse outcomes. Preliminary evidence from trials focusing on patients with multivessel disease has hinted at diabetes as a potential modifier of treatment outcomes.

Diabetes 122
article thumbnail

Durable versus biodegradable polymer drug-eluting stents in all-comers

Open Heart

Background Drug-eluting stents (DESs) have become the gold standard of coronary angioplasty since their inception in 2002. We aimed to compare outcomes between a broad range of second-generation DP-DES and BP-DES in an all-comer population. Conclusion Clinical follow-up up to 2 years shows similar outcomes between BP-DES and DP-DES.

Stents 52
article thumbnail

Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease

Cardiovascular Diabetology

Research design and methods All patients with diabetes and CAD undergoing a coronary angiography between 2010 and 2021 according to the Swedish Angiography and Angioplasty Registry were included. Results Among all patients (n = 38,671), 31% had stable CAD, and 69% suffered an acute myocardial infarction.

article thumbnail

Understanding the Difference Between Heart Attack and Cardiac Arrest

MIBHS

A heart attack, or myocardial infarction, happens when an artery becomes blocked, reducing blood flow to the heart muscle. Raising awareness and taking proactive steps can ensure the best possible outcomes for those at risk of heart-related conditions. What is a Heart Attack?

article thumbnail

BIDMC-led Trial Leads to FDA approval of Coronary Drug-coated Balloons

DAIC

milla1cf Wed, 03/13/2024 - 16:52 March 13, 2024 — In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty. and Susan F.

Stents 116
article thumbnail

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

This year’s theme, “Advancing Cardiovascular Care for All” brings the latest practice-changing breakthroughs, along with top experts debating and discussing outcomes of highly-anticipated clinical trials. 24 from April 6 - 8, 2024 in Atlanta, GA at the Georgia World Congress Center.

article thumbnail

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With or Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials

Circulation

BACKGROUND:Diabetes may be associated with differential outcomes in patients undergoing left main coronary revascularization with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). Circulation, Ahead of Print. 1.52]) or without (155/1634 [9.7%] versus 142/1655 [8.9%]; hazard ratio, 1.08 [95% CI, 0.86–1.36;PintHR=0.87)